Cargando…

Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial

Whole-body electromyostimulation (WB-EMS) induces high-intense stimuli to skeletal muscles with low strain on joints and the autonomic nervous system and may thus be suitable for frail, older people. However, if trained at very high intensities, WB-EMS may damage muscles and kidneys (rhabdomyolysis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloeckl, Joerg, Raps, Sebastian, Weineck, Michael, Kob, Robert, Bertsch, Thomas, Kemmler, Wolfgang, Schoene, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263209/
https://www.ncbi.nlm.nih.gov/pubmed/35812334
http://dx.doi.org/10.3389/fphys.2022.856681
_version_ 1784742678666149888
author Bloeckl, Joerg
Raps, Sebastian
Weineck, Michael
Kob, Robert
Bertsch, Thomas
Kemmler, Wolfgang
Schoene, Daniel
author_facet Bloeckl, Joerg
Raps, Sebastian
Weineck, Michael
Kob, Robert
Bertsch, Thomas
Kemmler, Wolfgang
Schoene, Daniel
author_sort Bloeckl, Joerg
collection PubMed
description Whole-body electromyostimulation (WB-EMS) induces high-intense stimuli to skeletal muscles with low strain on joints and the autonomic nervous system and may thus be suitable for frail, older people. However, if trained at very high intensities, WB-EMS may damage muscles and kidneys (rhabdomyolysis). This study aimed at investigating the feasibility, safety and preliminary efficacy of WB-EMS in frail, older people. Seven frail (81.3 ± 3.5 years), 11 robust (79.5 ± 3.6 years), 10 young (29.1 ± 6.4 years) participants completed an eight-week WB-EMS training (week 1–4: 1x/week; week 5–8: 1.5x/week) consisting of functional exercises addressing lower extremity strength and balance. Feasibility was assessed using recruitment, adherence, retention, and dropout rates. The satisfaction with WB-EMS was measured using the Physical Activity Enjoyment Scale for older adults (PACES-8). In week 1, 3, and 8 creatine kinase (CK) was assessed immediately before, 48 and 72 h after WB-EMS. Symptoms of rhabdomyolysis (muscle pain, muscle weakness, myoglobinuria) and adverse events were recorded. Functional capacity was assessed at baseline and after 8 weeks using the Short Physical Performance Battery (SPPB), Timed Up-and-Go Test (TUG), Choice Stepping Reaction Time Test (CSRT), 30-second Chair-Stand Test (30-STS), maximum isometric leg strength and handgrip strength. The recruitment rate of frail individuals was 46.2%, adherence 88.3% and the dropout rate 16.7%. All groups indicated a high satisfaction with WB-EMS. CK activity was more pronounced in young individuals with significant changes over time. Within older people CK increased borderline-significantly in the frail group from baseline to week 1 but not afterwards. In robust individuals CK increased significantly from baseline to week 1 and 3. No participant reached CK elevations close to the threshold of ≥5,000 U/l and no symptoms of rhabdomyolysis were observed. With the exception of the TUG (p = 0.173), frail individuals improved in all tests of functional capacity. Compared to the young and robust groups, frail individuals showed the greater improvements in the SPPB, handgrip strength, maximum isokinetic hip-/knee extension and flexion strength. WB-EMS is feasible for frail older people. There were no clinical signs of exertional rhabdomyolysis. WB-EMS proved to be sufficiently intense to induce meaningful changes in functional capacity with frail individuals showing greater improvements for several measures.
format Online
Article
Text
id pubmed-9263209
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92632092022-07-09 Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial Bloeckl, Joerg Raps, Sebastian Weineck, Michael Kob, Robert Bertsch, Thomas Kemmler, Wolfgang Schoene, Daniel Front Physiol Physiology Whole-body electromyostimulation (WB-EMS) induces high-intense stimuli to skeletal muscles with low strain on joints and the autonomic nervous system and may thus be suitable for frail, older people. However, if trained at very high intensities, WB-EMS may damage muscles and kidneys (rhabdomyolysis). This study aimed at investigating the feasibility, safety and preliminary efficacy of WB-EMS in frail, older people. Seven frail (81.3 ± 3.5 years), 11 robust (79.5 ± 3.6 years), 10 young (29.1 ± 6.4 years) participants completed an eight-week WB-EMS training (week 1–4: 1x/week; week 5–8: 1.5x/week) consisting of functional exercises addressing lower extremity strength and balance. Feasibility was assessed using recruitment, adherence, retention, and dropout rates. The satisfaction with WB-EMS was measured using the Physical Activity Enjoyment Scale for older adults (PACES-8). In week 1, 3, and 8 creatine kinase (CK) was assessed immediately before, 48 and 72 h after WB-EMS. Symptoms of rhabdomyolysis (muscle pain, muscle weakness, myoglobinuria) and adverse events were recorded. Functional capacity was assessed at baseline and after 8 weeks using the Short Physical Performance Battery (SPPB), Timed Up-and-Go Test (TUG), Choice Stepping Reaction Time Test (CSRT), 30-second Chair-Stand Test (30-STS), maximum isometric leg strength and handgrip strength. The recruitment rate of frail individuals was 46.2%, adherence 88.3% and the dropout rate 16.7%. All groups indicated a high satisfaction with WB-EMS. CK activity was more pronounced in young individuals with significant changes over time. Within older people CK increased borderline-significantly in the frail group from baseline to week 1 but not afterwards. In robust individuals CK increased significantly from baseline to week 1 and 3. No participant reached CK elevations close to the threshold of ≥5,000 U/l and no symptoms of rhabdomyolysis were observed. With the exception of the TUG (p = 0.173), frail individuals improved in all tests of functional capacity. Compared to the young and robust groups, frail individuals showed the greater improvements in the SPPB, handgrip strength, maximum isokinetic hip-/knee extension and flexion strength. WB-EMS is feasible for frail older people. There were no clinical signs of exertional rhabdomyolysis. WB-EMS proved to be sufficiently intense to induce meaningful changes in functional capacity with frail individuals showing greater improvements for several measures. Frontiers Media S.A. 2022-06-24 /pmc/articles/PMC9263209/ /pubmed/35812334 http://dx.doi.org/10.3389/fphys.2022.856681 Text en Copyright © 2022 Bloeckl, Raps, Weineck, Kob, Bertsch, Kemmler and Schoene. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Bloeckl, Joerg
Raps, Sebastian
Weineck, Michael
Kob, Robert
Bertsch, Thomas
Kemmler, Wolfgang
Schoene, Daniel
Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial
title Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial
title_full Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial
title_fullStr Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial
title_full_unstemmed Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial
title_short Feasibility and Safety of Whole-Body Electromyostimulation in Frail Older People—A Pilot Trial
title_sort feasibility and safety of whole-body electromyostimulation in frail older people—a pilot trial
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263209/
https://www.ncbi.nlm.nih.gov/pubmed/35812334
http://dx.doi.org/10.3389/fphys.2022.856681
work_keys_str_mv AT bloeckljoerg feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial
AT rapssebastian feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial
AT weineckmichael feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial
AT kobrobert feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial
AT bertschthomas feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial
AT kemmlerwolfgang feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial
AT schoenedaniel feasibilityandsafetyofwholebodyelectromyostimulationinfrailolderpeopleapilottrial